Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.

about

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.

Item

http://www.wikidata.org/entity/Q48320008

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@en

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@nl

type

Item

label

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@en

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@nl

prefLabel

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@en

Design and Discovery of Quinaz ...... nd VEGFR-2 Dual TK Inhibitors.

@nl

P1476

Design and Discovery of Quinaz ...... and VEGFR-2 Dual TK Inhibitors

@en

P2093

Fenghua Fu

http://www.w3.org/2001/XMLSchema#string

Jianwen Yao

http://www.w3.org/2001/XMLSchema#string

Jingwen Zhang

http://www.w3.org/2001/XMLSchema#string

Ningning Wang

http://www.w3.org/2001/XMLSchema#string

Shaofeng Sun

http://www.w3.org/2001/XMLSchema#string

Xiangkai Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Cell signaling by receptor tyrosine kinases

Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.

The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway.

Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.

TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics.

Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno[2,3-d]pyrimidines as irreversible epidermal growth factor receptor inhibitors.

Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.

Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking.

Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.

Design, synthesis and anticancer activities of diaryl urea derivatives bearing N-acylhydrazone moiety.

P31

scholarly article

P356

10.3390/MOLECULES23010024

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hongbo Wang

P577

2017-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29295519

http://www.w3.org/2001/XMLSchema#string

P932

5943947

http://www.w3.org/2001/XMLSchema#string